AWH Applauds DEA on Decision to Move Cannabis from Schedule I to Schedule III
NEW YORK, May 1, 2024 /PRNewswire/ – Ascend Wellness Holdings, Inc. (“AWH,” “Ascend” or the “Company”) (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, proudly announces support for the reports citing the Drug Enforcement Agency’s (“DEA”) decision to accept the recommendation of the U.S. Department of Health and Human Services (“HHS”) to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (“CSA”).
Related news for (AAWH)
- Ascend Wellness Holdings Closes $50 Million Private Placement of Senior Secured Notes
- Ascend Wellness Announces Grand Reopening of Detroit Dispensary, Its 38th Retail Location in the Nation, on February 28th
- Ascend Wellness Holdings Enters into Agency Agreement to Issue $15 Million of Senior Secured Notes
- Ascend Wellness Holdings Completes Repurchase of 11,000,000 Common Shares for Cancellation
- Curio Wellness and Ascend Wellness Announce Manufacturing and Distribution Partnership